Stockreport

MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13

MBX Biosciences, Inc.  (MBX) 
PDF CARMEL, Ind., Dec. 15, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and developmen [Read more]